Abstract
The review summarizes and systematizes data on the anti-inflammatory effect of the synthetic peptide LKEKK in vitro and in vivo. Based on the analysis, it was concluded that it has a significant therapeutic potential as an anti-inflammatory drug in Crohn's disease, various forms of colitis and contact dermatitis.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
